Skip to content

Examining the Impact of Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males

Examining the Impact of Acute Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males: A Randomized Cross-over Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03717948
Enrollment
13
Registered
2018-10-24
Start date
2018-10-01
Completion date
2019-01-28
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitochondrial Biogenesis

Keywords

Acute Exercise, Mitochondria, Skeletal Muscle, PGC1α, Mitochondrial Biogenesis, Intracellular Signalling

Brief summary

This crossover study investigates the effects of restricting arterial blood flow during cycling exercise on PGC-1α and its upstream signalling pathways. In a randomized order, participants will exercise once for 30 minutes with restricted blood flow and then will exercise once for 30 minutes with no blood flow restriction.

Interventions

OTHERBFR Exercise

Participants will exercise on a recumbent bike placed on a 45 degree incline (BFR).

OTHERCTL Exercise

Participants will exercise on a recumbent bike placed on flat ground (CTL).

Sponsors

Queen's University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Allocation concealment, assessor blinding

Eligibility

Sex/Gender
MALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* 3 hours of physical activity per week * No previous cycling training * No concurrent involvement in another training program * Body mass index \< 30 kg/m2

Exclusion criteria

* Presence of cardiovascular disease * Presence of metabolic disease * Taking regular oral medication * Current smoker

Design outcomes

Primary

MeasureTime frameDescription
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) messenger ribonucleic acid (mRNA)15 minutes before exercise and 3 hours post-exercise for both exercise sessionsFold-change in PGC-1α mRNA expression

Secondary

MeasureTime frameDescription
Total and phosphorylated p38 mitogen-activated protein kinase (MAPK)15 minutes before exercise and immediately post-exercise for both exercise sessionsFold change in p38 MAPK phosphorylation
Total and phosphorylated acetyl coenzyme A carboxylase (ACC)15 minutes before exercise and immediately post-exercise for both exercise sessionsFold change in ACC phosphorylation
Total and phosphorylated protein kinase A (PKA)15 minutes before exercise and immediately post-exercise for both exercise sessionsFold change in PKA phosphorylation
Acetylated p5315 minutes before exercise and immediately post-exercise for both exercise sessionsFold change in acetylated p53
Catecholamine concentrations15 minutes before exercise and immediately post-exercise for both exercise sessionsCatecholamine concentrations in venous blood
Heart rate (HR)During both exercise sessionsAverage HR between conditions
Revolutions per minute (RPM)During both exercise sessionsAverage RPM between conditions
Ratings of perceived exertion (RPE)During both exercise sessionsAverage RPE between conditions
Oxygenated and deoxygenated hemoglobinDuring both exercise sessions and up to 10 minutes after (for cuff occlusion)Average oxygenated and deoxygenated hemoglobin as a percentage of same day max values
Blood lactateDuring both exercise sessions (lactate); 15 minutes before and immediately after both exercise sessionsAverage \[lactate\] between conditions

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026